Advisor Group Holdings, Inc. Oncocyte Corp Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.25 - $15.6 $5,402 - $337,116	21,610 Added 760.92%	24,450 $7,000
Q2 2021 Aug 02, 2021	SELL	$3.77 - $6.0 $37,888 - $60,300	-10,050 Reduced 77.97%	2,840 $16,000
Q1 2021 May 13, 2021	BUY	$2.39 - $6.5 $28,314 - $77,005	11,847 Added 1135.86%	12,890 $67,000
Q4 2020 Feb 10, 2021	BUY	$1.38 - $2.63 $983 - $1,875	713 Added 216.06%	1,043 $2,000
Q3 2020 Nov 12, 2020	BUY	$1.2 - $1.89 $60 - $94	50 Added 17.86%	330 $0
Q1 2020 May 18, 2020	BUY	$1.76 - $3.02 $492 - $845	280 New	280 $1,000

399K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $238M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.